Clicky

Knight Therapeutics Inc.(GUD)

Description: Knight Therapeutics Inc is a Canada-based pharmaceutical company. The Company is engaged in developing, acquiring, in-licensing, out-licensing, marketing and distributing pharmaceutical products, consumer health products and medical devices in Canada and select international markets. It finances other life sciences companies in Canada and internationally. Its prescription pharmaceuticals and medical devices in various stages of development include Impavido, AzaSite, ATryn, Photofrin, ILUVIEN, TULSA-PRO, PROBUPHINE, Advaxis Family of Products, Ember Family of Products, NeurAxon Family of Products, Antibe Family of Products, Blood Factor Products and VEWS Vascular Early Warning System. In addition, the Company also has a portfolio of branded consumer health products, including Neuragen, Flat Tummy Tea, FOCUSFactor, FLEXISEQ, SEQuaderma, HandMD, UrgentRx, Laboratoire Dr. Renaud, Premiology and Pro-Derm.


Keywords: Pharmaceutical Life Sciences Pharmaceutical Products Science Pharmaceutical Sciences Pharma Labor Consumer Health Products Prescription Pharmaceuticals Renaud

Home Page: www.gud-knight.com

GUD Technical Analysis

3400 De Maisonneuve Boulevard West
Montreal, QC H3Z 3B8
Canada
Phone: 514 484 4483


Officers

Name Title
Mr. Jonathan Ross Goodman B.A., BA, L.L.B., LLB, M.B.A., MBA Exec. Chairman
Ms. Samira Sakhia BCom, CA, CPA, MBA Pres, CEO & Director
Mr. Arvind Utchanah Chief Financial Officer
Ms. Amal Khouri B.Sc., M.B.A. Chief Bus. Officer
Mr. Jeff Martens Global VP Commercial
Mr. Leopoldo Bosano Vice-Pres of Manufacturing & Operations
Ms. Daniela Marino Global VP of Legal & Compliance
Ms. Susan Caroline Emblem Global VP of HR
Ms. Jody Engel Sr. Director of Bus. Devel.

Exchange: TO

Country: CA

Currency: Canadian Dollar (C$)

Forward PE: 14.4928
Trailing PE: 0
Price-to-Book MRQ: 0.7028
Price-to-Sales TTM: 2.2186
IPO Date:
Fiscal Year End: December
Full Time Employees: 660
Back to stocks